Bioceres Crop Solutions Bolsa (NASDAQ: BIOX)

Últimas noticias sobre Bioceres Crop Solutions (NASDAQ:BIOX) Bolsa

Bioceres Crop Solutions

Bioceres Crop Solutions Corp is a fully-integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. The business divisions consist of crop protection, seed and integrated products, and crop nutrition. The company derives majority of its revenue from the crop protection division. Its product includes fertilizers, inoculants, adjuvants, crop protection solutions and seeds.

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions Corp

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics Inc

Bioxyne Ltd

Bioxytran Inc

Rosenblatt analyst Mike Genovese maintains Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) with a Buy and raises the price target from $20 to $27.5.

News

Price Target

Analyst Ratings

AAOI

Rosenblatt Maintains Buy on Applied Optoelectronics, Raises Price Target to $27.5

Rosenblatt analyst Kevin Cassidy maintains Synaptics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYNA#NASDAQ">SYNA</a>) with a Buy and lowers the price target from $130 to $92.

SYNA

Rosenblatt Maintains Buy on Synaptics, Lowers Price Target to $92

Rosenblatt analyst Kevin Cassidy maintains CEVA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEVA#NASDAQ">CEVA</a>) with a Buy and raises the price target from $28 to $35.

CEVA

Rosenblatt Maintains Buy on CEVA, Raises Price Target to $35

Rosenblatt analyst Kevin Cassidy maintains Adeia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADEA#NASDAQ">ADEA</a>) with a Buy and maintains $15 price target.

ADEA

Rosenblatt Maintains Buy on Adeia, Maintains $15 Price Target

Chardan Capital analyst Daniil Gataulin maintains EyePoint Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) with a Buy and raises the price target from $28 to $33.

EYPT

Chardan Capital Maintains Buy on EyePoint Pharmaceuticals, Raises Price Target to $33

Barrington Research analyst Alexander Paris maintains H&amp;R Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRB#NYSE">HRB</a>) with a Outperform and maintains $70 price target.

Barrington Research Maintains Outperform on H&R Block, Maintains $70 Price Target

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPK#NASDAQ">OPK</a>) with a Outperform and maintains $2.25 price target.

Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target

Macquarie analyst Tim Nollen maintains Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) with a Neutral and raises the price target from $8 to $9.

Macquarie Maintains Neutral on Warner Bros. Discovery, Raises Price Target to $9

BWS Financial analyst Hamed Khorsand maintains Arlo Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARLO#NYSE">ARLO</a>) with a Buy and maintains $24 price target.

ARLO

BWS Financial Maintains Buy on Arlo Technologies, Maintains $24 Price Target

Jones Trading analyst Matthew Erdner maintains Real Brokerage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) with a Buy and raises the price target from $6.5 to $7.

REAX

Jones Trading Maintains Buy on Real Brokerage, Raises Price Target to $7

Macquarie analyst Chad Beynon maintains Red Rock Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>) with a Outperform and lowers the price target from $65 to $64.

Macquarie Maintains Outperform on Red Rock Resorts, Lowers Price Target to $64

Macquarie analyst Chad Beynon maintains PENN Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) with a Outperform and raises the price target from $26 to $27.

PENN

Macquarie Maintains Outperform on PENN Entertainment, Raises Price Target to $27

Donald Trump&#8216;s winning the 2024 presidential election is expected to have a negative impact on <a href="https://www.benzinga.com/electric-vehicles">the electric vehicle sector</a>.
Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) could benefit from CEO Elon Musk's close relationship <a href="https://www.benzinga.com/markets/equities/24/11/41832876/elon-musk-shines-in-trump-sweepstakes-a-big-win-for-tesla-dan-ives-thinks-so">with the president-elect</a>. However, the company&#8217;s plan to build a Gigafactory in Mexico could be at stake.
What Happened: Tesla reportedly <a href="https://www.benzinga.com/news/24/02/37305137/tesla-to-kick-off-construction-of-giga-mexico-next-week-nuevo-le-n-governor-confirms">plans to build a gigafactory </a>in Mexico. The facility could produce sub-$30,000 vehicles, Model Y units, batteries and the Cybertruck.
Tesla hasn't confirmed its plans in Mexico. Still, the country's economic minister is asking questions after Trump won on Election Day.
"I'm going to set up a meeting with (Musk) soon so that he tells me exactly what he's thinking and see what we can do so this project moves forward," Mexico Economy Minister Marcelo Ebrard told local radio Thursday, as reported by Reuters.
Original plans for Mexico and other new factory locations may <a href="https://www.benzinga.com/news/23/06/33053957/tesla-gigafactory-mexico-opening-reportedly-delayed-to-early-2025-amid-logistical-hurdles">have been delayed</a> due to the election with Tesla saying in April that it would use its existing factories to build new more affordable vehicles.
Trump's past term in the White House put pressure on foreign-made items shipped to the United States. Prior to the 2024 election win, Trump<a href="https://www.benzinga.com/news/24/10/41397317/trump-defends-his-plans-to-impose-200-tariffs-on-cars-imported-from-china-mexico-hope-union-workers"> has been promising</a> to put a 200% tariff on vehicles imported from China and Mexico.
Tesla did not respond to a request for comment on its plans in Mexico to Benzinga.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent110824">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: Tesla has several gigafactories around the world that produce and export vehicles to key regions like Europe and Asia.
A gigafactory in Mexico was likely less about exports to other countries and more about bringing vehicles into the U.S.
Investors and analysts will continue monitoring Trump's win and whether it impacts Tesla and the EV sector.
Price Action: Tesla stock closed Friday up 8.1% to $321.22. The company hit a new 52-week high of $328.71 during the trading session. Tesla stock is up 31.5% over the last five days and up 29.3% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41501607/tesla-q3-earnings-highlights-eps-beat-revenue-miss-shares-climb-on-2025-timeline-for-lower-cost-evs">Tesla Q3 Earnings Highlights: EPS Beat, Revenue Miss, Shares Climb On 2025 Timeline For Lower-Cost EVs</a></li>
</ul>
Image: Shutterstock

Politics

Trading Ideas

TSLA

Elon Musk To Ditch Tesla Gigafactory In Mexico After Trump's Win? Economy Minister Wants 'A Meeting'

Macquarie analyst Chad Beynon maintains Golden Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDEN#NASDAQ">GDEN</a>) with a Outperform and lowers the price target from $39 to $38.

GDEN

Macquarie Maintains Outperform on Golden Entertainment, Lowers Price Target to $38

Macquarie analyst Tim Nollen maintains Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) with a Underperform and raises the price target from $15 to $16.

Macquarie Maintains Underperform on Unity Software, Raises Price Target to $16

Macquarie analyst Tim Nollen maintains Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Outperform and raises the price target from $130 to $133.

Macquarie Maintains Outperform on Trade Desk, Raises Price Target to $133

Macquarie analyst Tim Nollen maintains Magnite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) with a Outperform and maintains $18 price target.

MGNI

Macquarie Maintains Outperform on Magnite, Maintains $18 Price Target

WIIM

REVB

Revelation Biosciences shares are trading higher after the company reported better-than-expected Q3 EPS results.

NPABU

Trading Halt: Halt status updated at 4:40:00 PM ET: Quotation Resumption: News and Resumption Times

NPAB

Trading Halt: Halt status updated at 4:35:00 PM ET: Quotation Resumption: News and Resumption Times

There's a lot to be optimistic about in the Materials sector as 3 analysts just weighed in on Bioceres Crop Solutions (BIOX – Research Report), Mit...

Analysts Offer Insights on Materials Companies: Bioceres Crop Solutions (BIOX), Mitre Mining Corporation Limited (AU:ASL) and Capricorn Metals Ltd (AU:CMM)

Ben Klieve, an analyst from Lake Street, reiterated the Buy rating on Bioceres Crop Solutions (BIOX – Research Report). The associated price target...

Maintaining Buy on Bioceres: Adjusted Valuation Amid HB4 Wheat Setbacks

Roth MKM analyst Scott Fortune maintained a Buy rating on Bioceres Crop Solutions (BIOX – Research Report) today and set a price target of $13.00. ...

Bioceres Crop Solutions (BIOX) Receives a Buy from Roth MKM

In a report released today, Kristen Owen from Oppenheimer maintained a Buy rating on Bioceres Crop Solutions (BIOX – Research Report), with a price...

Oppenheimer Reaffirms Their Buy Rating on Bioceres Crop Solutions (BIOX)

Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices

Warning: BIOX is at high risk of performing badly

Bioceres Crop Solutions (BIOX) has released an update. Bioceres Crop Solutions Corp.'s audited financial statements for the years ending June 30, 2...

Bioceres Reports Stable Financial Position

Bioceres Crop Solutions (BIOX) has released an update. Bioceres Crop Solutions Corp. has announced its 2024 Annual General Meeting to be held on Oc...

Bioceres Announces 2024 Annual General Meeting

Catalyst Watch: Earnings blitz, Fed speakers, and notable healthcare conferences

Bioceres Crop Solutions (BIOX – Research Report), the Basic Materials sector company, was revisited by a Wall Street analyst today. Analyst Ben Kli...

Bioceres Crop Solutions: Strategic Buy Amid Resilience and Growth Potential

ALTM

ANRO

ASAN

AXNX

BIOX

BYON

CALM

CAMRF

DENN

ETON

FFIE

LOGI

MEDP

MNDY

QCOM

RIVN

TEAM

TMUS

UBER

WHLR

Press Releases

Bioceres Crop Solutions Reports Fiscal Second Quarter 2024 Financial and Operational Results

Bioceres Crop Solutions to Participate in the 36th Annual Roth Conference

Bioceres Crop Solutions to Host Fiscal Third Quarter 2024 Financial Results Conference Call on Tuesday, May 14, 2024 at 8:30 a.m. Eastern Time

Bioceres Crop Solutions Announces Brazil's Approval of New Generation Bio-Insecticide

Bioceres Crop Solutions to Participate in the BMO Global Farm to Market Conference

Bioceres Crop Solutions Reports Fiscal Third Quarter 2024 Financial and Operational Results

Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2024 Financial Results Conference Call on Tuesday, September 10, 2024 at 8:30 a.m. Eastern Time

Bioceres Crop Solutions Receives Green Light for Cultivation of Drought Tolerant HB4 Wheat in the United States

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2024 Financial and Operational Results

Bioceres Crop Solutions to Host Fiscal First Quarter 2025 Financial Results Conference Call on Tuesday, November 12, 2024 at 8:30 a.m. Eastern Time

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

China Green Agriculture, Inc. Common Stock

China Green Agriculture

Corteva

Intrepid Potash

Mosaic

N2OFF

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

Comments

Bioceres Crop Solutions

Noticias

Últimas noticias sobre Bioceres Crop Solutions (NASDAQ:BIOX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL